Effects of peripherally restricted κ opioid receptor agonists on pain-related stimulation and depression of behavior in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 340, Issue 3, 2012, Pages 501-509

  Negus, S Stevens ^a   O'Connell, Robert ^a   Morrissey, Ember ^a   Cheng, Kejun ^b   Rice, Kenner C ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [1 (3,4 DICHLORO N METHYLPHENYLACETAMIDO) 2 (1 PYRROLIDINYL)ETHYL]PHENOXYACETIC ACID; DEXTRO PHENYLALANINE DEXTRO PHENYLALANINE DEXTRO ISOLEUCINE DEXTRO ARGININE AMIDE; FE 200041; KAPPA OPIATE RECEPTOR AGONIST; KETOPROFEN; SALVINORIN A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SELECTIVITY; DRUG STRUCTURE; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DITERPENES, CLERODANE; FLUPENTHIXOL; KETOPROFEN; MALE; OLIGOPEPTIDES; PAIN; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SELF STIMULATION;

EID: 84857281021     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.186783     Document Type: Article

References (41)

1. Ansonoff MA, Zhang J, Czyzyk T, Rothman RB, Stewart J, Xu H, Zjwiony J, Siebert DJ, Yang F, Roth BL, et al. (2006) Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of ≲κα ππα∀-opioid receptor-1 knockout mice. J Pharmacol Exp Ther 318:641-648. (Pubitemid 44061239)
2. Arendt-Nielsen L, Olesen AE, Staahl C, Menzaghi F, Kell S, Wong GY, and Drewes AM (2009) Analgesic efficacy of peripheral ≲καππ α∀-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain. Anesthesiology 111:616-624.
3. Baggott MJ, Erowid E, Erowid F, Galloway GP, and Mendelson J (2010) Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend 111:250-256.
4. Barber A, Bartoszyk GD, Greiner HE, Mauler F, Murray RD, Seyfried CA, Simon M, Gottschlich R, Harting J, and Lues I (1994) Central and peripheral actions of the novel ≲καππα∀-opioid receptor agonist, EMD 60400. Br J Pharmacol 111:843-851. (Pubitemid 24151674)
5. Caram-Salas NL, Reyes-García G, Bartoszyk GD, Araiza-Saldaña CI, Ambriz-Tututi M, Rocha-González HI, Arreola-Espino R, Cruz SL, and Granados-Soto V (2007) Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat. Eur J Pharmacol 573:75-83. (Pubitemid 47495904)
6. Carey GJ and Bergman J (2001) Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists. J Pharmacol Exp Ther 297:215-223. (Pubitemid 32242581)
7. Carlezon WA Jr, Béguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, and Cohen BM (2006) Depressive-like effects of the ≲καππα∀-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447. (Pubitemid 41832624)
8. Chartoff EH, Potter D, Damez-Werno D, Cohen BM, and Carlezon WA Jr (2008) Exposure to the selective ≲καππα∀-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology 33:2676-2687.
9. Cleeland CS and Ryan KM (1994) Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129-138.
10. Corbett D (1990) Differences in sensitivity to neuroleptic blockade: medial forebrain bundle versus frontal cortex self-stimulation. Behav Brain Res 36:91-96.
11. Delvaux M, Beck A, Jacob J, Bouzamondo H, Weber FT, and Frexinos J (2004) Effect of asimadoline, a ≲καππα∀ opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 20:237-246. (Pubitemid 38998223)
12. Dooley CT, Ny P, Bidlack JM, and Houghten RA (1998) Selective ligands for the μ, δ, ann ≲καππα∀ opioid receptors identified from a single mixture based tetrapeptide positional scanning combinatorial library. J Biol Chem 273:18848-18856. (Pubitemid 28366271)
13. Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, et al. (2005) Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113:9-19. (Pubitemid 40038441)
14. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
15. Johanson CE and Fischman MW (1989) The pharmacology of cocaine related to its abuse. Pharmacol Rev 41:3-52.
16. Keïta H, Kayser V, and Guilbaud G (1995) Antinociceptive effect of a ≲καππα∀a-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur J Pharmacol 277:275-280.
17. Machelska H, Pflüger M, Weber W, Piranvisseh-Völk M, Daubert JD, Dehaven R, and Stein C (1999) Peripheral effects of the ≲κα ππα∀-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J Pharmacol Exp Ther 290:354-361. (Pubitemid 29302343)
18. Mangel AW, Bornstein JD, Hamm LR, Buda J, Wang J, Irish W, and Urso D (2008) Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther 28:239-249. (Pubitemid 351861967)
19. McCurdy CR, Sufka KJ, Smith GH, Warnick JE, and Nieto MJ (2006) Antinociceptive profile of salvinorin A, a structurally unique ≲καππα∀ opioid receptor agonist. Pharmacol Biochem Behav 83:109-113.
20. Mogil JS (2009) Animal models of pain: progress and challenges. Nat Rev Neurosci 10:283-294.
21. Negus SS, Bilsky EJ, Pereira Do Carmo G and Stevenson GW (2010a) Rationale and methods for assessment of pain-depressed behavior in preclinical assays of pain and analgesia, in Methods in Molecular Biology: Analgesia (Szallasi A ed) pp 79-91, Humana Press, New York.
22. Negus SS, Morrissey EM, Rosenberg M, Cheng K, and Rice KC (2010b) Effects of κ opioids in an assay of pain-depressed intracranial self-stimulation in rats. Psychopharmacology (Berl) 210:149-159.
23. Negus SS, Vanderah TW, Brandt MR, Bilsky EJ, Becerra L, and Borsook D (2006) Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J Pharmacol Exp Ther 319:507-514.
24. Nielsen IM, Pedersen V, Nymark M, Franck KF, Boeck V, Fjalland B, and Christensen AV (1973) The comparative pharmacology of flupenthixol and some reference neuroleptics. Acta Pharmacol Toxicol 33:353-362.
25. Nolan AM (2000) Pharmacology of analgesic drugs, in Pain Management in Animals (Flecknell PA and Waterman-Pearson A eds) pp 21-52, Elsevier, Philadelphia.
26. Pande AC, Pyke RE, Greiner M, Cooper SA, Benjamin R, and Pierce MW (1996a) Analgesic efficacy of the ≲καππα∀- receptor agonist, enadoline, in dental surgery pain. Clin Neuropharmacol 19:92-97. (Pubitemid 26026326)
27. Pande AC, Pyke RE, Greiner M, Wideman GL, Benjamin R, and Pierce MW (1996b) Analgesic efficacy of enadoline versus placebo or morphine in postsurgical pain. Clin Neuropharmacol 19:451-456. (Pubitemid 26314864)
28. Pereira Do Carmo G, Stevenson GW, Carlezon WA, and Negus SS (2009) Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144:170-177.
29. Prisinzano TE (2005) Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sci 78:527-531.
30. Sarzi-Puttini P, Atzeni F, Lanata L, Bagnasco M, Colombo M, Fischer F, and D'Imporzano M (2010) Pain and ketoprofen: what is its role in clinical practice? Reumatismo 62:172-188.
31. Seguin L, Le Marouille-Girardon S, and Millan MJ (1995) Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparis on to other classes of antinociceptive agent. Pain 61:325-343.
32. Shaw JS, Carroll JA, Alcock P, and Main BG (1989) ICI 204448: a ≲καππα∀-opioid agonist with limited access to the CNS. Br J Pharmacol 96:986-992. (Pubitemid 19100058)
33. Spofford CM, Ashmawi H, Subieta A, Buevich F, Moses A, Baker M, and Brennan TJ (2009) Ketoprofen produces modality-specific inhibition of pain behaviors in rats after plantar incision. Anesth Analg 109:1992-1999.
34. Stevenson GW, Bilsky EJ, and Negus SS (2006) Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. J Pain 7:408-416. (Pubitemid 43794888)
35. Stevenson GW, Cormier J, Mercer H, Adams C, Dunbar C, Negus SS, and Bilsky EJ (2009) Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci 85:309-315.
36. Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, and Zinsmeister AR (2007) Efficacy of on-demand asimadoline, a peripheral ≲καππα∀-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol 5:1268-1275. (Pubitemid 350019057)
37. Vadivelu N, Mitra S, and Hines RL (2011) Peripheral opioid receptor agonists for analgesia: a comprehensive review. J Opioid Manag 7:55-68.
38. Vanderah TW, Largent-Milnes T, Lai J, Porreca F, Houghten RA, Menzaghi F, Wisniewski K, Stalewski J, Sueiras-Diaz J, Galyean R, et al. (2008) Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral ≲καππα∀-opioid receptors. Eur J Pharmacol 583:62-72.
39. 2): A peripheral efficacious ≲καππα∀ opioid agonist with unprecedented selectivity. J Pharmacol Exp Ther 310:326-333.
40. Wadenberg ML (2003) A review of the properties of spiradoline: a potent and selective ≲καππα∀-opioid receptor agonist. CNS Drug Rev 9:187-198.
41. Zhang Y, Butelman ER, Schlussman SD, Ho A, and Kreek MJ (2005) Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at κopioid receptors. Psychopharmacology (Berl) 179:551-558. (Pubitemid 40674756)